Neurodegeneration With Brain Iron Accumulation 6 C4517377
A genetic disorder causing iron buildup in the brain, leading to movement problems and neurological decline. It typically begins in childhood and worsens over time. Treatment focuses on managing symptoms and supportive care.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Visual impairment
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Optic atrophy
(neurologic)Nystagmus
(neurologic)Photophobia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Iron Chelation Therapy
Iron chelating agents are the primary disease-directed therapy to reduce iron accumulation in brain structures. Treatment requires regular monitoring of iron indices and potential side effects.
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
Botulinum Toxin Injections for Focal Dystonia
Targeted botulinum toxin injections can manage focal dystonia in specific muscle groups, improving comfort and function. Effects typically last 3-4 months requiring repeat treatments.
Additional treatment options
Neuroprotective Antioxidant Protocol
High-dose antioxidant supplementation including vitamins E and C, Coenzyme Q10, and alpha-lipoic acid may provide neuroprotection by reducing oxidative damage. Considered adjunctive therapy.
dietaryMultidisciplinary Rehabilitation Program
Comprehensive rehabilitation including physical, occupational, and speech therapy addresses the multifaceted impairments in NBIA. Regular therapy maintains function and prevents secondary complications.
physical_therapyComprehensive Disease Progression Surveillance
Regular assessments of neurological function, brain imaging, and iron studies track disease progression and treatment response. Enables timely intervention for emerging complications.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Neurodegeneration With Brain Iron Accumulation 6 C4517377?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Neurodegeneration With Brain Iron Accumulation 6 C4517377. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy